Bioanalytical techniques in nontargeted clinical lipidomics

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Shevchenko A, Simons K. Lipidomics: coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 11(8), 593–598 (2010).
  Medline CASGoogle Scholar
• 2 Rolim AE, Henrique-Araujo R, Ferraz EG, De Araujo Alves Dultra FK, Fernandez LG. Lipidomics in the study of lipid metabolism: current perspectives in the omic sciences. Gene 554(2), 131–139 (2015).
  Medline CASGoogle Scholar
• 3 Cajka T, Fiehn O. Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Anal. Chem. 61, 192–206 (2014). • A comprehensive review on the LC–MS application in lipidomics.
  Medline CASGoogle Scholar
• 4 Sandra K, Sandra P. Lipidomics from an analytical perspective. Curr. Opin. Chem. Biol. 17(5), 847–853 (2013).•• A comprehensive review of instrumental aspects in lipidomics.
  Medline CASGoogle Scholar
• 5 Blanksby SJ, Mitchell TW. Advances in mass spectrometry for lipidomics. Annual Rev. Anal. Chem. 3, 433–465 (2010).
  Medline CASGoogle Scholar
• 6 Jørgenrud B, Jäntti S, Mattila I et al. The influence of sample collection methodology and sample preprocessing on the blood metabolic profile. Bioanalysis 7(8), 991–1006 (2015).
  CASGoogle Scholar
• 7 Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom. Rev. 31(1), 134–178 (2012).
  Medline CASGoogle Scholar
• 8 Ishikawa M, Maekawa K, Saito K et al. Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects’ gender and age. PLoS ONE 9(3), e91806 (2014).
  MedlineGoogle Scholar
• 9 Weir JM, Wong G, Barlow CK et al. Plasma lipid profiling in a large population-based cohort. J. Lipid Res. 54(10), 2898–2908 (2013).
  Medline CASGoogle Scholar
• 10 Cai X, Perttula K, Pajouh SK, Hubbard A, Nomura DK, Rappaport SM. . Untargeted lipidomic profiling of human plasma reveals differences due to race, gender and smoking status. J. Postgenomics Drug Biomarker Dev. 4, 131 (2014).
  Google Scholar
• 11 Deo RC, Reich D, Tandon A et al. Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study. PLoS Genet. 5(1), e1000342 (2009).
  MedlineGoogle Scholar
• 12 Kim K, Mall C, Taylor SL et al. Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment. PLoS ONE 9(1), e86223 (2014).
  MedlineGoogle Scholar
• 13 Perez-Caballero AI, Alcala-Diaz JF, Perez-Martinez P et al. Lipid metabolism after an oral fat test meal is affected by age-associated features of metabolic syndrome, but not by age. Atherosclerosis 226(1), 258–262 (2013).
  Medline CASGoogle Scholar
• 14 Bondia-Pons I, Maukonen J, Mattila I et al. Metabolome and fecal microbiota in monozygotic twin pairs discordant for weight: a Big Mac challenge. FASEB J. 28(9), 4169–4179 (2014).
  Medline CASGoogle Scholar
• 15 Fusconi E, Pala V, Riboli E et al. Relationship between plasma fatty acid composition and diet over previous years in the Italian centers of the European Prospective Investigation into Cancer and Nutrition (EPIC). Tumori 89(6), 624–635 (2003).
  Medline CASGoogle Scholar
• 16 Lankinen M, Schwab U, Erkkila A et al. Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. PLoS ONE 4(4), e5258 (2009).
  MedlineGoogle Scholar
• 17 Urquiaga I, Guasch V, Marshall G et al. Effect of Mediterranean and Occidental diets, and red wine, on plasma fatty acids in humans. An intervention study. Biol. Res. 37(2), 253–261 (2004).
  MedlineGoogle Scholar
• 18 Lankinen M, Schwab U, Kolehmainen M et al. Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study. PLoS ONE 6(8), e22646 (2011).
  Medline CASGoogle Scholar
• 19 Krajcovicova-Kudlackova M, Simoncic R, Bederova A, Grancicova E, Magalova T. Influence of vegetarian and mixed nutrition on selected haematological and biochemical parameters in children. Nahrung 41(5), 311–314 (1997).
  Medline CASGoogle Scholar
• 20 Bondia-Pons I, Pöhö P, Bozzetto L et al. Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk. Mol. Nutr. Food Res. 58(9), 1873–1882 (2014).
  Medline CASGoogle Scholar
• 21 Krug S, Kastenmuller G, Stuckler F et al. The dynamic range of the human metabolome revealed by challenges. FASEB J. 26(6), 2607–2619 (2012).
  Medline CASGoogle Scholar
• 22 Kim M, Suk J, Kim H, Jung H, Kim T, Park J. Post-prandial lipid levels for assessing target goal achievement in Type 2 diabetic patients taking statin. J. Korean Med. Sci. 25(3), 387–392 (2010).
  Medline CASGoogle Scholar
• 23 Choi JM, Kim TE, Cho JY, Lee HJ, Jung BH. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 944, 157–165 (2014).
  Medline CASGoogle Scholar
• 24 Snowden SG, Grapov D, Settergren M et al. High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy. Circulation 7(6), 955–964 (2014).
  Medline CASGoogle Scholar
• 25 Breier M, Wahl S, Prehn C et al. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. PLoS ONE 9(2), e89728 (2014).
  MedlineGoogle Scholar
• 26 Zivkovic AM, Wiest MM, Nguyen UT, Davis R, Watkins SM, German JB. Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics 5(4), 507–516 (2009). • Study on the effect of preanalytical factors on lipid analysis.
  Medline CASGoogle Scholar
• 27 Alsaif M, Guest PC, Schwarz E et al. Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection. Proteomics Clin. Appl. 6(5–6), 297–303 (2012).
  Medline CASGoogle Scholar
• 28 Hammad SM, Pierce JS, Soodavar F et al. Blood sphingolipidomics in healthy humans: impact of sample collection methodology. J. Lipid Res. 51(10), 3074–3087 (2010).
  Medline CASGoogle Scholar
• 29 Yang W, Chen Y, Xi C et al. Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites’ stability on reliability of potential biomarkers. Anal. Chem. 85(5), 2606–2610 (2013).
  Medline CASGoogle Scholar
• 30 Taylor LA, Arends J, Hodina AK, Unger C, Massing U. Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status. Lipids Health Dis. 6, 17 (2007).
  MedlineGoogle Scholar
• 31 Lessig J, Fuchs B. Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Curr. Med. Chem. 16(16), 2021–2041 (2009).
  Medline CASGoogle Scholar
• 32 Onorato JM, Shipkova P, Minnich A, Aubry AF, Easter J, Tymiak A. Challenges in accurate quantitation of lysophosphatidic acids in human biofluids. J. Lipid Res. 55(8), 1784–1796 (2014).
  Medline CASGoogle Scholar
• 33 Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226(1), 497–509 (1957).
  Medline CASGoogle Scholar
• 34 Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49(5), 1137–1146 (2008).
  Medline CASGoogle Scholar
• 35 Sarafian MH, Gaudin M, Lewis MR et al. Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography-mass spectrometry. Anal. Chem. 86(12), 5766–5774 (2014).
  Medline CASGoogle Scholar
• 36 Hyotylainen T, Oresic M. Optimizing the lipidomics workflow for clinical studies-practical considerations. Anal. Bioanal. Chem. 407(17), 4973–4993 (2015).•• A review of preanalytical and analytical parameters in clinical lipidomics.
  Medline CASGoogle Scholar
• 37 Orešič M, Hyötyläinen T, Kotronen A et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia 56(10), 2266–2274 (2013).
  Medline CASGoogle Scholar
• 38 Oresic M, Gopalacharyulu P, Mykkanen J et al. Cord serum lipidome in prediction of islet autoimmunity and Type 1 diabetes. Diabetes 62(9), 3268–3274 (2013).
  Medline CASGoogle Scholar
• 39 Yang K, Cheng H, Gross RW, Han X. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal. Chem. 81(11), 4356–4368 (2009).
  Medline CASGoogle Scholar
• 40 Houjou T, Yamatani K, Imagawa M, Shimizu T, Taguchi R. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Comm. Mass Spectrom. 19(5), 654–666 (2005).
  Medline CASGoogle Scholar
• 41 Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS ONE 4(7), e6261 (2009).
  MedlineGoogle Scholar
• 42 Nikkila J, Sysi-Aho M, Ermolov A et al. Gender-dependent progression of systemic metabolic states in early childhood. Mol. Syst. Biol. 4, 197 (2008).
  MedlineGoogle Scholar
• 43 Mittelstrass K, Ried JS, Yu Z et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 7(8), e1002215 (2011).
  Medline CASGoogle Scholar
• 44 Gooley JJ, Chua EC. Diurnal regulation of lipid metabolism and applications of circadian lipidomics. J. Genet. Genomics 41(5), 231–250 (2014).
  Medline CASGoogle Scholar
• 45 Chua EC, Shui G, Lee IT et al. Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc. Natl Acad. Sci. USA 110(35), 14468–14473 (2013).
  Medline CASGoogle Scholar
• 46 Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA. The human circadian metabolome. Proc. Natl Acad. Sci. USA 109(7), 2625–2629 (2012).
  Medline CASGoogle Scholar
• 47 Ang JE, Revell V, Mann A et al. Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach. Chronobiol. Int. 29(7), 868–881 (2012).
  Medline CASGoogle Scholar
• 48 Kasukawa T, Sugimoto M, Hida A et al. Human blood metabolite timetable indicates internal body time. Proc. Natl Acad. Sci. USA 109(37), 15036–15041 (2012).
  Medline CASGoogle Scholar
• 49 Bonham MP, Linderborg KM, Dordevic A et al. Lipidomic profiling of chylomicron triacylglycerols in response to high fat meals. Lipids 48(1), 39–50 (2013).
  Medline CASGoogle Scholar
• 50 Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118(20), 2047–2056 (2008).
  Medline CASGoogle Scholar
• 51 Zivkovic AM, Wiest MM, Nguyen U, Nording ML, Watkins SM, German JB. Assessing individual metabolic responsiveness to a lipid challenge using a targeted metabolomic approach. Metabolomics 5(2), 209–218 (2009).
  Medline CASGoogle Scholar
• 52 Krajcovicova-Kudlackova M, Simoncic R, Klvanova J, Bederova A, Babinska K, Grancicova E. [The plasma profile of fatty acids in vegetarians]. Bratislavske lekarske listy 98(1), 23–27 (1997).
  Medline CASGoogle Scholar
• 53 Bondia-Pons I, Poho P, Bozzetto L et al. Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk. Mol. Nutr. Food Res. 58(9), 1873–1882 (2014).
  Medline CASGoogle Scholar
• 54 Becan-Mcbride K. Laboratory sampling: does the process affect the outcome? J. Infus. Nurs. 22(3), 137 (1999).
  CASGoogle Scholar
• 55 Gonzalez-Covarrubias V, Dane A, Hankemeier T, Vreeken RJ. The influence of citrate, EDTA, and heparin anticoagulants to human plasma LC-MS lipidomic profiling. Metabolomics 9(2), 337–348 (2013).
  CASGoogle Scholar
• 56 Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68–69:3–58 (2002).
  Google Scholar
• 57 Max Scherer GS, Gerhard Liebisch. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. Clin. Chem. 55(6), 5 (2009).
  MedlineGoogle Scholar
• 58 Brugger B. Lipidomics: analysis of the lipid composition of cells and subcellular organelles by electrospray ionization mass spectrometry. Ann. Rev. Biochem. 83, 79–98 (2014).
  MedlineGoogle Scholar
• 59 Lam SM, Shui G. Lipidomics as a principal tool for advancing biomedical research. J. Genet. Genomics 40(8), 375–390 (2013).
  Medline CASGoogle Scholar
• 60 Li M, Yang L, Bai Y, Liu H. Analytical methods in lipidomics and their applications. Anal. Chem. 86(1), 161–175 (2014).
  Medline CASGoogle Scholar
• 61 Sandra K, Pereira Ados S, Vanhoenacker G, David F, Sandra P. Comprehensive blood plasma lipidomics by liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Chromatogr. A 1217(25), 4087–4099 (2010). • Comprehensive analysis of lipids with LC–MS.
  Medline CASGoogle Scholar
• 62 Zhao YY, Wu SP, Liu S, Zhang Y, Lin RC. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem. Biol. Interact. 220, 181–192 (2014).
  Medline CASGoogle Scholar
• 63 Holcapek M, Jirasko R, Lisa M. Recent developments in liquid chromatography-mass spectrometry and related techniques. J. Chromatogr. A 1259 3–15 (2012).
  Medline CASGoogle Scholar
• 64 Lisa M, Holcapek M. High-throughput and comprehensive lipidomic analysis using ultrahigh-performance supercritical fluid chromatography-mass spectrometry. Anal. Chem. 87(14), 7187–7195 (2015).
  Medline CASGoogle Scholar
• 65 Zhong Y, Hyung SJ, Ruotolo BT. Characterizing the resolution and accuracy of a second-generation traveling-wave ion mobility separator for biomolecular ions. Analyst 136(17), 3534–3541 (2011).
  Medline CASGoogle Scholar
• 66 Holcapek M, Ovcacikova M, Lisa M, Cifkova E, Hajek T. Continuous comprehensive two-dimensional liquid chromatography-electrospray ionization mass spectrometry of complex lipidomic samples. Anal. Bioanal. Chem. 407(17), 5033–5043 (2015).
  Medline CASGoogle Scholar
• 67 Gao X, Zhang Q, Meng D et al. A reversed-phase capillary ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) method for comprehensive top-down/bottom-up lipid profiling. Anal. Bioanal. Chem. 402(9), 2923–2933 (2012).
  Medline CASGoogle Scholar
• 68 Bang DY, Lim S, Moon MH. Effect of ionization modifiers on the simultaneous analysis of all classes of phospholipids by nanoflow liquid chromatography/tandem mass spectrometry in negative ion mode. J. Chromatogr. A 1240 69–76 (2012).
  Medline CASGoogle Scholar
• 69 Kliman M, May JC, Mclean JA. Lipid analysis and lipidomics by structurally selective ion mobility-mass spectrometry. Biochim. Biophys. Acta 1811(11), 935–945 (2011).
  Medline CASGoogle Scholar
• 70 Shah V, Castro-Perez JM, Mclaren DG, Herath KB, Previs SF, Roddy TP. Enhanced data-independent analysis of lipids using ion mobility-TOFMSE to unravel quantitative and qualitative information in human plasma. Rapid Commun. Mass Spectrom. 27(19), 2195–2200 (2013).
  Medline CASGoogle Scholar
• 71 Xiao JF, Zhou B, Ressom HW. Metabolite identification and quantitation in LC-MS/MS-based metabolomics. Trends Analyt. Chem. 32 1–14 (2012).
  MedlineGoogle Scholar
• 72 Foster JM, Moreno P, Fabregat A et al. LipidHome: a database of theoretical lipids optimized for high throughput mass spectrometry lipidomics. PLoS ONE 8(5), e61951 (2013).
  Medline CASGoogle Scholar
• 73 Kind T, Liu KH, Lee Do Y, Defelice B, Meissen JK, Fiehn O. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat. Methods 10(8), 755–758 (2013).•• A comprehensive article of lipid identification.
  Medline CASGoogle Scholar
• 74 Pham HT, Trevitt AJ, Mitchell TW, Blanksby SJ. Rapid differentiation of isomeric lipids by photodissociation mass spectrometry of fatty acid derivatives. Rapid Commun. Mass Spectrom. 27(7), 805–815 (2013).
  Medline CASGoogle Scholar
• 75 Pham HT, Ly T, Trevitt AJ, Mitchell TW, Blanksby SJ. Differentiation of complex lipid isomers by radical-directed dissociation mass spectrometry. Anal. Chem. 84(17), 7525–7532 (2012).
  Medline CASGoogle Scholar
• 76 Katajamaa M, Oresic M. Data processing for mass spectrometry-based metabolomics. J. Chromatogr. A 1158(1–2), 318–328 (2007).
  Medline CASGoogle Scholar
• 77 Castillo S, Gopalacharyulu P, Yetukuri L, Orešič M. Algorithms and tools for the preprocessing of LC-MS metabolomics data. Chemometr. Intell. Lab. Syst. 108, 23–32 (2011).
  CASGoogle Scholar
• 78 Husen P, Tarasov K, Katafiasz M et al. Analysis of lipid experiments (ALEX): a software framework for analysis of high-resolution shotgun lipidomics data. PLoS ONE 8(11), e79736 (2013).
  Medline CASGoogle Scholar
• 79 Herzog R, Schwudke D, Schuhmann K et al. A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language. Genome Biol. 12(1), R8 (2011).
  Medline CASGoogle Scholar
• 80 Song H, Hsu FF, Ladenson J, Turk J. Algorithm for processing raw mass spectrometric data to identify and quantitate complex lipid molecular species in mixtures by data-dependent scanning and fragment ion database searching. J. Am. Soc. Mass Spectrom. 18(10), 1848–1858 (2007).
  Medline CASGoogle Scholar
• 81 Haimi P, Uphoff A, Hermansson M, Somerharju P. Software tools for analysis of mass spectrometric lipidome data. Anal. Chem. 78(24), 8324–8331 (2006).
  Medline CASGoogle Scholar
• 82 Leavell MD, Leary JA. Fatty acid analysis tool (FAAT): an FT-ICR MS lipid analysis algorithm. Anal. Chem. 78(15), 5497–5503 (2006).
  Medline CASGoogle Scholar
• 83 Hubner G, Crone C, Lindner B. lipID-a software tool for automated assignment of lipids in mass spectra. J. Mass Spectrom. 44(12), 1676–1683 (2009).
  MedlineGoogle Scholar
• 84 Ejsing CS, Duchoslav E, Sampaio J et al. Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal. Chem. 78(17), 6202–6214 (2006).
  Medline CASGoogle Scholar
• 85 Schwudke D, Oegema J, Burton L et al. Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal. Chem. 78(2), 585–595 (2006).
  Medline CASGoogle Scholar
• 86 Lommen A. MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal. Chem. 81(8), 3079–3086 (2009).
  Medline CASGoogle Scholar
• 87 Katajamaa M, Oresic M. Processing methods for differential analysis of LC/MS profile data. BMC Bioinform. 6, 179 (2005).
  MedlineGoogle Scholar
• 88 Smith CA, Want EJ, O’maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78(3), 779–787 (2006).
  Medline CASGoogle Scholar
• 89 Styczynski MP, Moxley JF, Tong LV, Walther JL, Jensen KL, Stephanopoulos GN. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Anal. Chem. 79(3), 966–973 (2007).
  Medline CASGoogle Scholar
• 90 Coble JB, Fraga CG. Comparative evaluation of preprocessing freeware on chromatography/mass spectrometry data for signature discovery. J. Chromatogr. A 1358, 155–164 (2014).•• Comparison of the software tools for lipidomics data preprocessing.
  Medline CASGoogle Scholar
• 91 Han X, Gross RW. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc. Natl Acad. Sci. USA 91(22), 10635–10639 (1994).
  Medline CASGoogle Scholar
• 92 Brugger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl Acad. Sci. USA 94(6), 2339–2344 (1997).
  Medline CASGoogle Scholar
• 93 Koivusalo M, Haimi P, Heikinheimo L, Kostiainen R, Somerharju P. Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J. Lipid Res. 42(4), 663–672 (2001).
  MedlineGoogle Scholar
• 94 Wheelock C, Goto S, Yetukuri L et al. Bioinformatics strategies for the analysis of lipids. In: Lipidomics. Armstrong D (Ed.). Humana Press, NY, USA 339–368 (2010).
  Google Scholar
• 95 Van Iersel MP, Kelder T, Pico AR et al. Presenting and exploring biological pathways with PathVisio. BMC Bioinform. 9, 399 (2008).
  MedlineGoogle Scholar
• 96 Junker BH, Klukas C, Schreiber F. VANTED: a system for advanced data analysis and visualization in the context of biological networks. BMC Bioinform. 7, 109 (2006).
  MedlineGoogle Scholar
• 97 Byrnes RW, Cotter D, Maer A, Li J, Nadeau D, Subramaniam S. An editor for pathway drawing and data visualization in the Biopathways Workbench. BMC Syst. Biol. 3, 99 (2009).
  MedlineGoogle Scholar
• 98 Zhao YY, Cheng XL, Vaziri ND, Liu S, Lin RC. UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clin. Biochem. 47(15), 16–26 (2014).
  Medline CASGoogle Scholar
• 99 Orešič M, Seppänen-Laakso T, Sun D et al. Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 4(1), 1 (2012).
  Medline CASGoogle Scholar
• 100 Shui G, Lam SM, Stebbins J et al. Polar lipid derangements in Type 2 diabetes mellitus: potential pathological relevance of fatty acyl heterogeneity in sphingolipids. Metabolomics 9(4), 786–799 (2013).
  CASGoogle Scholar
• 101 Kotronen A, Velagapudi VR, Yetukuri L et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52(4), 684–690 (2009).
  Medline CASGoogle Scholar
• 102 Rhee EP, Cheng S, Larson MG et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Invest. 121(4), 1402–1411 (2011).
  Medline CASGoogle Scholar
• 103 Suhre K, Meisinger C, Doring A et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 5(11), e13953 (2010). • Comprehensive metabolic profiling of diabetic subjects using three parallel analytical platforms.
  MedlineGoogle Scholar
• 104 Puri P, Wiest MM, Cheung O et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50(6), 1827–1838 (2009).
  Medline CASGoogle Scholar
• 105 Muir K, Hazim A, He Y et al. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res. 73(15), 4722–4731 (2013).
  Medline CASGoogle Scholar
• 106 Stegemann C, Pechlaner R, Willeit P et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 129(18), 1821–1831 (2014).
  Medline CASGoogle Scholar
• 107 Wang-Sattler R, Yu Z, Herder C et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol. Syst. Biol. 8, 615 (2012).
  MedlineGoogle Scholar
• 108 Floegel A, Stefan N, Yu Z et al. Identification of serum metabolites associated with risk of Type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2), 639–648 (2013).
  Medline CASGoogle Scholar
• 109 Cobb J, Eckhart A, Perichon R et al. A novel test for IGT utilizing metabolite markers of glucose tolerance. J. Diabetes Sci. Technol. 9(1), 69–76 (2015).
  Medline CASGoogle Scholar
• 110 Ferrannini E, Natali A, Camastra S et al. Early metabolic markers of the development of dysglycemia and Type 2 diabetes and their physiological significance. Diabetes 62(5), 1730–1737 (2013).
  Medline CASGoogle Scholar
• 111 Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and Type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2(1), 65–75 (2014).
  Medline CASGoogle Scholar
• 112 Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am. J. Gastroenterol. 104(4), 861–867 (2009).
  MedlineGoogle Scholar
• 113 Oresic M, Hyotylainen T, Kotronen A et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia 56(10), 2266–2274 (2013).
  Medline CASGoogle Scholar
• 114 Kotronen A, Velagapudi VR, Yetukuri L et al. Saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52(4), 684–690 (2009).
  Medline CASGoogle Scholar